Semax Research for Neuroprotection
An evidence-based overview of research examining Semax in the context of neuroprotection. This page synthesizes findings from peer-reviewed literature.
Research Summary
Semax demonstrates broad neuroprotective effects through multiple mechanisms including neurotrophin upregulation, anti-inflammatory activity, and immunomodulation. The peptide rapidly increases BDNF and NGF expression (up to 8-fold within 30 minutes), supporting neuronal survival and repair.
Preclinical studies in ischemia-reperfusion models confirm reduced infarct volume, improved transcriptome profiles, and suppression of pro-inflammatory mediators. The neuroprotective effects extend beyond stroke to general CNS protection in various injury models.
Recent research from Chinese institutions has demonstrated benefits in spinal cord injury through mu-opioid receptor targeting, expanding the potential neuroprotective applications beyond the original Russian research focus.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Neuroprotection
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Semax may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.